Transforming the treatment of invasive fungal infections
Elion Therapeutics is a biotechnology company focused on combating life-threatening invasive fungal infections. Our goal is to provide patients and clinicians with new therapies that address critical unmet needs in antifungal efficacy and safety.
Our seasoned leadership represents more than 200 years of collective expertise in the development of antifungal drugs. Our experience ranges from large pharma to academia and from bench to bedside. Our passion for protecting patients drives our long-standing dedication to developing critically needed new ways to treat invasive fungal infections. Our depth and breadth in the antifungal space uniquely positions Elion Therapeutics for success in this mission.